LeMaitre Vascular shareholders back directors and pay

LeMaitre Vascular, Inc. reported the results of its 2026 Annual Meeting of Stockholders.

(Moderate)

(Negative)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

8-K

Rhea-AI Filing Summary

LeMaitre Vascular, Inc. reported the results of its 2026 Annual Meeting of Stockholders. A total of 22,847,798 shares were entitled to vote as of April 6, 2026, and 21,336,301 shares were represented in person or by proxy.

Stockholders elected two Class II directors to three-year terms: David B. Roberts received 18,888,412 votes for and 1,250,012 withheld, while John A. Roush received 14,229,071 votes for and 5,909,353 withheld. An advisory vote approved executive compensation with 19,311,813 votes for and 813,052 against. Stockholders also ratified Grant Thornton LLP as independent registered public accounting firm for 2026 with 21,220,412 votes for and 108,474 against.

8-K Event Classification

Item 5.07 — Submission of Matters to a Vote of Security Holders

1 item

Item 5.07 Submission of Matters to a Vote of Security Holders Governance

Results of a shareholder vote on proposals at an annual or special meeting.

Key Figures

Shares entitled to vote: 22,847,798 shares Shares represented: 21,336,301 shares Votes for David B. Roberts: 18,888,412 shares +3 more

6 metrics

Shares entitled to vote 22,847,798 shares Common stock entitled to vote as of April 6, 2026

Shares represented 21,336,301 shares Shares present in person or by proxy at 2026 Annual Meeting

Votes for David B. Roberts 18,888,412 shares Election of Class II director, Proposal 1

Votes for John A. Roush 14,229,071 shares Election of Class II director, Proposal 1

Votes for executive compensation 19,311,813 shares Advisory vote on named executive officer pay, Proposal 2

Votes for auditor ratification 21,220,412 shares Ratification of Grant Thornton LLP for 2026, Proposal 3

Key Terms

broker non-votes, advisory vote on the compensation, independent registered public accounting firm, Annual Meeting of Stockholders

4 terms

broker non-votes financial

"David B. Roberts received a vote of 18,888,412 shares for, 1,250,012 shares withheld and 1,197,877 broker non-votes."

Broker non-votes occur when a brokerage firm is unable to vote on a shareholder’s behalf during a company election or decision because the shareholder has not given specific voting instructions, and the broker is not allowed or chooses not to vote on certain matters. They are important because they can affect the outcome of votes, especially when the results are close, by effectively reducing the total number of votes cast.

advisory vote on the compensation financial

"an advisory vote on the compensation of the Company’s named executive officers"

independent registered public accounting firm financial

"the ratification of the appointment of Grant Thornton LLP as the Company’s independent registered public accounting firm for 2026"

An independent registered public accounting firm is an outside accounting company officially registered with the government regulator to examine and report on a public company's financial records and controls. Investors treat its reports like an impartial inspector’s certificate — they add credibility to financial statements, help spot errors or misleading claims, and reduce the risk that shareholders are relying on unchecked or biased numbers.

Annual Meeting of Stockholders financial

"held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”)."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did LeMaitre Vascular (LMAT) stockholders vote on at the 2026 Annual Meeting?

Stockholders voted on electing two Class II directors, approving executive compensation on an advisory basis, and ratifying Grant Thornton LLP as independent registered public accounting firm for 2026. All three proposals received majority support based on votes cast.

How many LeMaitre Vascular (LMAT) shares were represented at the 2026 Annual Meeting?

Out of 22,847,798 shares entitled to vote as of April 6, 2026, 21,336,301 shares were present in person or represented by proxy at the Annual Meeting. This indicates a high level of stockholder participation in the voting process.

Were LeMaitre Vascular (LMAT) director nominees elected at the 2026 Annual Meeting?

Yes, both Class II director nominees were elected. David B. Roberts received 18,888,412 votes for and 1,250,012 withheld, while John A. Roush received 14,229,071 votes for and 5,909,353 withheld, with 1,197,877 broker non-votes for each nominee.

Did LeMaitre Vascular (LMAT) stockholders approve executive compensation in 2026?

Stockholders approved the company’s executive compensation on an advisory basis. The vote was 19,311,813 shares for and 813,052 shares against, with 13,559 abstentions and 1,197,877 broker non-votes, indicating majority support for the pay practices.

Who is LeMaitre Vascular’s (LMAT) independent auditor for 2026?

Grant Thornton LLP was ratified as the independent registered public accounting firm for the year ending December 31, 2026. The ratification received 21,220,412 votes for, 108,474 votes against, and 7,415 abstentions from stockholders at the Annual Meeting.

What are broker non-votes in LeMaitre Vascular’s (LMAT) 2026 Annual Meeting results?

Broker non-votes are shares held by brokers that were not voted on certain proposals. In this meeting, there were 1,197,877 broker non-votes on the director elections and the advisory executive compensation proposal, but these did not prevent majority approval.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 06/04/2026 - 07:41 PM

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

     Date of Report (Date of earliest event reported): June 02, 2026

    

LeMaitre Vascular, Inc.

(Exact name of Registrant as Specified in Its Charter)


Delaware	001-33092	04-2825458
(State or Other Jurisdiction of Incorporation)	(Commission File Number)	(IRS Employer Identification No.)

63 Second Avenue
Burlington, Massachusetts		01803
(Address of Principal Executive Offices)		(Zip Code)

     Registrant’s Telephone Number, Including Area Code: 781 221-2266

    

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common stock, $0.01 par value per share	LMAT	The Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.07 Submission of Matters to a Vote of Security Holders.

(a) On June 2, 2026, LeMaitre Vascular, Inc. (the "Company") held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”). A total of 22,847,798 shares of the Company’s common stock were entitled to vote as of April 6, 2026, the record date for the Annual Meeting, of which 21,336,301 shares were present in person or represented by proxy at the Annual Meeting.

(b) Matters voted upon by the stockholders at the Annual Meeting were: (i) the election of two Class II directors nominated by the Board of Directors for three-year terms; (ii) an advisory vote on the compensation of the Company’s named executive officers; and (iii) the ratification of the appointment of Grant Thornton LLP as the Company’s independent registered public accounting firm for 2026.

Set forth below is information concerning each matter submitted to a vote at the Annual Meeting.

Proposal No. 1 – Election of Directors

By a majority of votes cast, the stockholders elected each of the following two nominees as a Class II director for a term of three years expiring upon the 2029 Annual Meeting of Stockholders or until their successor has been duly elected and qualified. David B. Roberts received a vote of 18,888,412 shares for, 1,250,012 shares withheld and 1,197,877 broker non-votes. John A. Roush received a vote of 14,229,071 shares for, 5,909,353 shares withheld and 1,197,877 broker non-votes.

Proposal No. 2 – Advisory Vote on Executive Compensation

By a majority of votes cast, the stockholders approved, on an advisory basis, the Company's executive compensation by a vote of 19,311,813 shares for and 813,052 shares against, with 13,559 shares abstaining and 1,197,877 broker non-votes.

Proposal No. 3 – Ratification of the Selection of Independent Registered Public Accounting Firm

By a majority of votes cast, the stockholders ratified the selection of Grant Thornton LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026 with a vote of 21,220,412 shares for and 108,474 shares against, with 7,415 shares abstaining.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


			LEMAITRE VASCULAR, INC.

Date:	June 4, 2026	By:	/s/Dorian P. LeBlanc
			Name: Dorian P. LeBlanc Title: Chief Financial Officer

Source: View Original Filing on SEC EDGAR

Filing Exhibits & Attachments

1 document